Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 22, 2017
Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral ImmunityDavid Olagnier, Rassin R Lababidi, Samar Bel Hadj, et al.
Virus Research|July 31, 2020
Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training networkBernadette van den Hoogen, Angela Santoni, Giuseppe Sciumé, et al.
Cancer Cell|October 31, 2003
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.
Cytokine & Growth Factor Reviews|February 21, 2021
Anticancer innovative therapy congress: Highlights from the 10th anniversary editionFrancesca De Santis, Giovanni Fucà, Dirk Schadendorf, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2010
A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizersJean-Simon Diallo, Fabrice Le Boeuf, Frances Lai, et al.
Immunity|July 4, 2012
The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagyYu Lei, Haitao Wen, Yanbao Yu, et al.
International Journal of Molecular Sciences|July 14, 2023
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening StrategyGiulia Marsili, Chiara Acchioni, Anna Lisa Remoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2008
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysisThi Lien-Anh Nguyên, Hesham Abdelbary, Meztli Arguello, et al.
Plos Pathogens|September 28, 2020
SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activitySimone De Meo, Valentina Dell'Oste, Rosa Molfetta, et al.
Plos Pathogens|May 2, 2013
Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivityMarie-Line Goulet, David Olagnier, Zhengyun Xu, et al.
Pageof 16